Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Liposomes are not better than acetone for applying DHT on skin.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Early onset hair loss linked to genetics and androgen levels.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Suppressing certain hormones might help prevent prostate cancer.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Finasteride may increase depression by reducing brain cell growth.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.